U.S. market projected at USD 0.91 billion and Europe at USD 0.76 billion by 2035, driven by cancer diagnostics, PET-CT/PET-MRI adoption, and advanced molecular imaging
Austin, United States, Aug. 21, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the global Positron Emission Tomography Scan Market was valued at USD 1.86 billion in 2025 and is projected to reach USD 2.81 billion by 2035, expanding at a CAGR of 4.26% from 2026 to 2035. The factors driving the growth of the market include increasing use of PET scan technology for detecting and managing cancers, evaluating heart problems, diagnosing neuropsychiatric disorders, and increased application of PET-CT and PET-MRI modalities.
Growing demand for more efficient imaging, an aging population, increased healthcare spending, and the need for early and preventive diagnosis are also fueling the use of PET imaging. Healthcare infrastructure investments and the development of digital PET scanners, novel radiotracers, AI-assisted imaging, and whole-body PET scanners are expanding the technological environment.
Research the market before purchase: Download the Positron Emission Tomography Scan Market Sample Report
Cancer Burden and Hybrid Imaging Adoption Support Long-Term PET Scan Market Growth
There has been an increased incidence of cancer, heart diseases, and neurological diseases leading to the increasing requirement of imaging technologies that will aid in diagnosing early on, as well as treatment and management of such diseases. PET-CT imaging technology is still very vital for this need since it has both anatomical and functional information, whereas PET-MRI imaging is becoming increasingly popular.
Molecular imaging is also being increasingly used in hospitals, diagnostic imaging facilities, and research laboratories as personalized medicine evolves into an accepted practice. Moreover, digital PET systems, image analysis software with artificial intelligence (AI), new radiopharmaceuticals, and whole body PET scans are paving new ways in terms of workflow and clinical applications.
Key PET Scan Market Takeaways
- Leading product: PET-CT Systems (Hybrid), approximately 82.00% share in 2025
- Leading modality: Fixed PET Scanners, approximately 93.10% share in 2025
- Leading application: Oncology, approximately 55.00% share in 2025
- Leading end user: Hospitals & Surgical Centers, more than 50.00% share in 2025
- Largest regional market: North America, approximately 41.50% share in 2025
- Fastest-growing regional market: Asia Pacific
Regional Analysis: U.S. and Europe Add Value as North America Leads
North America is expected to hold about 41.50% of the market share in 2025. The prominent share of North America can be attributed to factors such as well-established health care system, wide-scale implementation of molecular imaging techniques, high prevalence of cancer and other chronic ailments, favorable reimbursement scenario, and substantial penetration of PET-CT and PET-MRI scanners.
United States: The U.S. PET scan market size is estimated to be around USD 0.68 billion in 2025 and is expected to touch USD 0.91 billion by 2035, growing at a CAGR of 2.98% from 2026 to 2035. The market growth is driven by robust imaging infrastructure and increased molecular imaging application in large clinical applications.
Europe: The Europe Positron Emission Tomography Scan Market was valued at USD 0.52 billion in 2025 and is expected to reach USD 0.76 billion by 2035, growing at a CAGR of 4.10% from 2026 to 2035. Established healthcare infrastructure, aging population, and preference for sophisticated imaging techniques drive this region’s market.
Asia Pacific: The Asia Pacific region is considered the fastest-growing regional market due to the growth in health care expenditure, high incidence of cancer, and improved availability of high-end imaging technologies in China, India, Japan, South Korea, and Australia. China had an estimated 29.00% share in the regional market, which was aided by infrastructure development and increased emphasis on hybrid imaging devices.
PET Scan Market Segmentation Highlights
By Product: PET-CT Systems (Hybrid) dominated the market with a share of about 82%, attributable to the potential of these systems to integrate functional and anatomical images in oncology, cardiology, and neurology. The PET-MRI Systems are projected to grow at the highest rate, driven by the need for soft tissue imaging, low-radiation, neurological use, pediatric use, and precision medicine.
By Modality: Fixed PET Scanners accounted for about 93.10% market share in 2025 due to wide availability in hospitals and clinics, along with use in hybrid imaging on a large scale. It is forecast that Portable/Mobile PET Scanners will grow at a rapid pace, as providers are increasingly seeking imaging capabilities at the point of care.
By Application: Oncology accounted for the biggest market share of over 55.00% in 2025 due to its use in the diagnosis, staging, treatment planning, and therapeutic surveillance of patients suffering from cancer. Neurology is projected to have the fastest-growing application segment because of the increasing use of PET imaging for conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and brain mapping.
By End User: Hospitals & Surgical Centers accounted for more than 50.00% of the market in 2025, supported by access to PET-CT and PET-MRI systems, chronic disease diagnostic volumes, and reimbursement coverage. Diagnostic & Imaging Centers are identified as the fastest-growing end-user segment as demand for outpatient imaging and efficient diagnostic services expands.
Positron Emission Tomography Scan Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 1.86 Billion |
| Market Size by 2035 | USD 2.81 Billion |
| CAGR | CAGR of 4.26% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Product (PET-CT Systems (Hybrid), PET-MRI Systems, Standalone PET Systems) • By Modality (Fixed PET Scanners, Portable / Mobile PET Scanners) • By Application (Oncology, Cardiology, Neurology, Orthopedics & Others) • By End User (Hospitals & Surgical Centers, Diagnostic & Imaging Centers, Academic & Research Institutes, Ambulatory Care Centers & Others) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Companies Covered in the PET Scan Market Report
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- Shimadzu Corporation
- Mediso Ltd.
- Neusoft Medical Systems
- MinFound Medical Systems
- IBA Radiopharma Solutions
- Eckert & Ziegler
- Cubresa Inc.
- Positron Corporation
- SOFIE Biosciences
- PerkinElmer
- Bruker Corporation
- Cardinal Health
- Lantheus Medical Imaging
- Blue Earth Diagnostics
- FluoroPharma Medical
Recent Developments:
- 2025: Canon Medical Systems unveiled its next-generation Alphenix 4D CT integrated with Aquilion ONE / INSIGHT Edition at CIRSE 2025, supporting advanced hybrid imaging applications.
- 2024: GE HealthCare announced a USD 960 million investment in India to expand manufacturing and R&D capabilities for PET-CT diagnostic imaging systems and related medical devices.
Buy the Positron Emission Tomography Scan Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/10175
Frequently Asked Questions
What is the expected CAGR of the Positron Emission Tomography Scan Market from 2026 to 2035?
The market is expected to grow at a CAGR of 4.26% from 2026 to 2035.
What was the size of the Positron Emission Tomography Scan Market in 2025?
The market was valued at USD 1.86 billion in 2025.
What are the major growth drivers for the PET scan market?
The report identifies rising cancer incidence, demand for earlier disease detection, growing use of advanced hybrid imaging, healthcare investment, and expanding adoption of PET-CT and PET-MRI systems as major growth drivers.
Which product segment dominated the Positron Emission Tomography Scan Market in 2025?
PET-CT Systems (Hybrid) led the market with approximately 82.00% share in 2025.
Which region dominated the Positron Emission Tomography Scan Market in 2025?
North America led the market with approximately 41.50% share in 2025.
How large are the U.S. and Europe PET scan markets expected to be by 2035?
The U.S. market is projected to reach approximately USD 0.91 billion by 2035, while Europe is projected to reach USD 0.76 billion by 2035.
Related Market Reports
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315-961-9094 (US) Email: info@snsinsider.com
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!